These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 30940711)

  • 21. Mechanism of action of antibody to capsular polysaccharide in Cryptococcus neoformans infection.
    Feldmesser M; Casadevall A
    Front Biosci; 1998 Feb; 3():d136-51. PubMed ID: 9445465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of human monoclonal antibodies elicited by vaccination with a Cryptococcus neoformans glucuronoxylomannan capsular polysaccharide vaccine.
    Pirofski L; Lui R; DeShaw M; Kressel AB; Zhong Z
    Infect Immun; 1995 Aug; 63(8):3005-14. PubMed ID: 7622223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cryptococcus neoformans
    Zhang L; Zhang K; Li H; Coelho C; de Souza Gonçalves D; Fu MS; Li X; Nakayasu ES; Kim YM; Liao W; Pan W; Casadevall A
    mBio; 2021 Mar; 12(2):. PubMed ID: 33785616
    [No Abstract]   [Full Text] [Related]  

  • 24. Semisynthetic Glycoconjugate Vaccine Candidates against
    Crawford CJ; Liporagi-Lopes L; Coelho C; Santos Junior SR; Moraes Nicola A; Wear MP; Vij R; Oscarson S; Casadevall A
    ACS Infect Dis; 2024 Jun; 10(6):2089-2100. PubMed ID: 38819951
    [No Abstract]   [Full Text] [Related]  

  • 25. Glucuronoxylomannan in the Cryptococcus species capsule as a target for Chimeric Antigen Receptor T-cell therapy.
    da Silva TA; Hauser PJ; Bandey I; Laskowski T; Wang Q; Najjar AM; Kumaresan PR
    Cytotherapy; 2021 Feb; 23(2):119-130. PubMed ID: 33303326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Innate host defenses against Cryptococcus neoformans.
    Hole C; Wormley FL
    J Microbiol; 2016 Mar; 54(3):202-11. PubMed ID: 26920880
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glucuronoxylomannan intranasal challenge prior to Cryptococcus neoformans pulmonary infection enhances cerebral cryptococcosis in rodents.
    Lee HH; Carmichael DJ; Ríbeiro V; Parisi DN; Munzen ME; Charles-Niño CL; Hamed MF; Kaur E; Mishra A; Patel J; Rooklin RB; Sher A; Carrillo-Sepulveda MA; Eugenin EA; Dores MR; Martinez LR
    PLoS Pathog; 2023 Apr; 19(4):e1010941. PubMed ID: 37115795
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Feasibility and prospects for a vaccine to prevent cryptococcosis.
    Casadevall A; Pirofski LA
    Med Mycol; 2005 Dec; 43(8):667-80. PubMed ID: 16422296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protection of mice against experimental cryptococcosis using glucan particle-based vaccines containing novel recombinant antigens.
    Hester MM; Lee CK; Abraham A; Khoshkenar P; Ostroff GR; Levitz SM; Specht CA
    Vaccine; 2020 Jan; 38(3):620-626. PubMed ID: 31699504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preclinical efficacy of a glucuronoxylomannan-tetanus toxoid conjugate vaccine of Cryptococcus neoformans in a murine model.
    Devi SJ
    Vaccine; 1996 Jun; 14(9):841-4. PubMed ID: 8843625
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibodies elicited by a Cryptococcus neoformans-tetanus toxoid conjugate vaccine have the same specificity as those elicited in infection.
    Casadevall A; Mukherjee J; Devi SJ; Schneerson R; Robbins JB; Scharff MD
    J Infect Dis; 1992 Jun; 165(6):1086-93. PubMed ID: 1583327
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Gonçalves DS; Rodriguez de La Noval C; Ferreira MDS; Honorato L; Araújo GRS; Frases S; Pizzini CV; Nosanchuk JD; Cordero RJB; Rodrigues ML; Peralta JM; Nimrichter L; Guimarães AJ
    Front Cell Infect Microbiol; 2020; 10():565571. PubMed ID: 33585262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of multiple components involved in the interaction between Cryptococcus neoformans and Acanthamoeba castellanii.
    Rizzo J; Albuquerque PC; Wolf JM; Nascimento R; Pereira MD; Nosanchuk JD; Rodrigues ML
    Fungal Biol; 2017; 121(6-7):602-614. PubMed ID: 28606355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective efficacy of antigenic fractions in mouse models of cryptococcosis.
    Mansour MK; Yauch LE; Rottman JB; Levitz SM
    Infect Immun; 2004 Mar; 72(3):1746-54. PubMed ID: 14977983
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protective and nonprotective human immunoglobulin M monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan manifest different specificities and gene use profiles.
    Maitta RW; Datta K; Chang Q; Luo RX; Witover B; Subramaniam K; Pirofski LA
    Infect Immun; 2004 Aug; 72(8):4810-8. PubMed ID: 15271943
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunomodulatory Role of Capsular Polysaccharides Constituents of
    Decote-Ricardo D; LaRocque-de-Freitas IF; Rocha JDB; Nascimento DO; Nunes MP; Morrot A; Freire-de-Lima L; Previato JO; Mendonça-Previato L; Freire-de-Lima CG
    Front Med (Lausanne); 2019; 6():129. PubMed ID: 31275938
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunological correlates of protection mediated by a whole organism,
    Specht CA; Wang R; Oliveira LVN; Hester MM; Gomez C; Mou Z; Carlson D; Lee CK; Hole CR; Lam WC; Upadhya R; Lodge JK; Levitz SM
    mBio; 2024 Aug; 15(8):e0174624. PubMed ID: 38980038
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-glucuronoxylomannan IgG1 specific antibodies production in Cryptococcus neoformans resistant mice.
    Parra C; González JM; Castañeda E; Fiorentino S
    Biomedica; 2005 Mar; 25(1):110-9. PubMed ID: 15962907
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Roles for CD40, B7 and major histocompatibility complex in induction of enhanced immunity by cryptococcal polysaccharide-pulsed antigen-presenting cells.
    Blackstock R
    Immunology; 2003 Feb; 108(2):158-66. PubMed ID: 12562324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glucosylceramide Administration as a Vaccination Strategy in Mouse Models of Cryptococcosis.
    Mor V; Farnoud AM; Singh A; Rella A; Tanno H; Ishii K; Kawakami K; Sato T; Del Poeta M
    PLoS One; 2016; 11(4):e0153853. PubMed ID: 27082428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.